Skip Navigation

University of Nebraska–Lincoln

Nebraska Center for Virology

The Strength of Cooperation Among Three Institutions

Tsuneya Ikezu, MD, PhD

Associate Professor
University of Nebraska Medical Center
Center for Neurovirology and Neurodegenerative Disorders
985215 Nebraska Medical Center
Omaha, NE 68198-5880
Phone - 402.559.9565
Fax - 402.559.3744
tikezu@unmc.edu

Research Interests:

Our research focuses on the molecular pathogenesis of Alzheimer's disease (AD) and HIV-associated dementia (HAD). The hypothesis being tested here is that chronic brain inflammatory reactions contribute to the progressive neurodegeneration often observed during AD. Such an idea is substantiated by a recent report that anti-inflammatory drugs slow the onset and progression of disease, including A b deposition. Neuron-microglial interaction is being studied in both animal models and primary culture systems.

Our laboratory is also involved in the molecular characterization of mononuclear phagocyte activation upon HIV-1 infection. We have recently characterized a novel transcriptional factor, OTK18, which is expressed in human macrophage upon HIV-1 infection and has anti-retroviral activity in vitro. We are investigating the molecular mechanism of the anti-retroviral effect of OTK18 as a transcriptional factor. These studies will lead to extension of our understanding of HIV-1 associated dementia and AD. Multiple experimental methods, including molecular biology, neurobiology, and immunology, are utilized for the investigation.

Select Publications (last 3 years):

  1. Yamamoto M, Horiba M, Buescher JL, Huang DR, Gendelman HE, Ransohoff RM, and Ikezu T. Overexpression of monocyte chemotactic protein-1 (MCP)-1/CCL2 in _-amyloid precursor protein transgenic mice show accelerated diffuse b-amyloid deposition. Am J Pathol, in press (2005)
  2. Carlson KA, Leisman G, Limoges J, Pohlman GD, Horiba M, Buescher JL, Gendelman HE, and Ikezu T. Molecular characterization of a novel anti-retroviral transcriptional factor, OTK18. J Immunol 172:381-391 (2004)
  3. Carlson KA, Limoges J, Pohlman GD, Masliah E, Ikezu T, and Gendelman HE. OTK18: A novel macrophage transcriptional suppressive factor linked to HIV encephalitis. J Neuroimmunol, 150:186-198 (2004)
  4. Xiong H, McCabe L, Castello JK, Anderson ER, Weber GA, Monagham D, and Ikezu T. Activation of NR1a/NR2B receptors by macrophage conditioned media stimulated with APP-processing products: Implications for Alzheimer’s disease. Neurobiol Aging 25:905-911 (2004)
  5. Li X, Ikezu T, and Hexum TD. G Protein bg Subunits Mediate the NPY Enhancement of ATP-Stimulated InsP Formation in Bovine Chromaffin Cells. PEPTIDES 25:267-74 (2004)
  6. Ikezu T, Luo X, Weber GA, Zhao J, McCabe L, Buescher JL, Ghorpade A, Zheng J, and Xiong H. Amyloid precursor protein-processing products affects mononuclear phagocytes activation: Differential function of sAPP and A_ for neurotoxicity. J Neurochem 85:925-934 (2003)
  7. Luo X, Weber GA, Zheng J, Gendelman HE, and Ikezu T. C1q-calreticulin induced oxidative neurotoxicity: Relevance for the neuropathgenesis of Alzheimer’s disease. J Neuroimmunol, 135:62-71 (2003)
  8. Li X, Zhang P, Drakulich DA, Shen M, Weber GA, Ikezu T, and Hexum TD. Infection of Bovine Adrenal Chromaffin Cells Using a Recombinant Adenovirus Expressing GFP. J Neurosci Methods 122:91-96 (2002)